Kaplan–Meier analysis indicated a poorer survival of MDS patients with lower ZBTB38 expression (below the median) in comparison with higher ZBTB38 (above the median), although not statistically significant (P = 0.054) (Fig. 6c). The gene discussed is ZBTB38; the disease is myelodysplastic syndrome.